106 related articles for article (PubMed ID: 1973455)
1. An inhibitor of endopeptidase-24.15 blocks the degradation of intraventricularly administered dynorphins.
Molineaux CJ; Ayala JM
J Neurochem; 1990 Aug; 55(2):611-8. PubMed ID: 1973455
[TBL] [Abstract][Full Text] [Related]
2. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG
Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422
[TBL] [Abstract][Full Text] [Related]
3. Synaptosomal membrane-bound form of endopeptidase-24.15 generates Leu-enkephalin from dynorphin1-8, alpha- and beta-neoendorphin, and Met-enkephalin from Met-enkephalin-Arg6-Gly7-Leu8.
Acker GR; Molineaux C; Orlowski M
J Neurochem; 1987 Jan; 48(1):284-92. PubMed ID: 2878974
[TBL] [Abstract][Full Text] [Related]
4. Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitor.
Telford SE; Smith AI; Lew RA; Perich RB; Madden AC; Evans RG
Br J Pharmacol; 1995 Mar; 114(6):1185-92. PubMed ID: 7620708
[TBL] [Abstract][Full Text] [Related]
5. Dynorphins and Leu-enkephalin in brain nuclei and pituitary of WKY and SHR rats.
Feuerstein G; Molineaux CJ; Rosenberger JG; Faden AI; Cox BM
Peptides; 1983; 4(2):225-9. PubMed ID: 6622288
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of [Leu5]-enkephalin in three isolated preparations: relative importance of aminopeptidase, endopeptidase-24.11 and peptidyl dipeptidase A.
Oka T; Aoki K; Kajiwara M; Ishii K; Kuno Y; Hiranuma T; Matsumiya T
NIDA Res Monogr; 1986; 75():259-62. PubMed ID: 2828976
[TBL] [Abstract][Full Text] [Related]
7. Evidence that enzymatic conversion of N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala-Phe-p-aminobenzoate, a specific inhibitor of endopeptidase 24.15, to N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala is necessary for inhibition of angiotensin converting enzyme.
Cardozo C; Orlowski M
Peptides; 1993; 14(6):1259-62. PubMed ID: 8134308
[TBL] [Abstract][Full Text] [Related]
8. Endopeptidase 24.15 inhibition and opioid antinociception.
Kest B; Orlowski M; Bodnar RJ
Psychopharmacology (Berl); 1992; 106(3):408-16. PubMed ID: 1349191
[TBL] [Abstract][Full Text] [Related]
9. Involvement of endopeptidase 24.15 in the inactivation of bradykinin by rat brain slices.
McDermott JR; Gibson AM; Turner JD
Biochem Biophys Res Commun; 1987 Jul; 146(1):154-8. PubMed ID: 2886123
[TBL] [Abstract][Full Text] [Related]
10. A novel synthetic inhibitor of endopeptidase-24.15.
Ukai Y; Li Q; Ito S; Mita S
J Enzyme Inhib; 1996 Aug; 11(1):39-49. PubMed ID: 9204395
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive properties of inhibitors of endopeptidase 24.15.
Kest B; Orlowski M; Molineaux CJ; Bodnar RJ
Int J Neurosci; 1991; 56(1-4):141-9. PubMed ID: 1938129
[TBL] [Abstract][Full Text] [Related]
12. Dynorphin A processing enzyme: tissue distribution, isolation, and characterization.
Berman Y; Ageyeva L; Veksler B; Wood D; Devi LA
J Biochem; 1999 Mar; 125(3):641-7. PubMed ID: 10050055
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of endopeptidase 24.15 slows the in vivo degradation of luteinizing hormone-releasing hormone.
Lasdun A; Reznik S; Molineaux CJ; Orlowski M
J Pharmacol Exp Ther; 1989 Nov; 251(2):439-47. PubMed ID: 2681686
[TBL] [Abstract][Full Text] [Related]
14. Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo.
Lew RA; Tomoda F; Evans RG; Lakat L; Boublik JH; Pipolo LA; Smith AI
Br J Pharmacol; 1996 Jul; 118(5):1269-77. PubMed ID: 8818353
[TBL] [Abstract][Full Text] [Related]
15. Formation of [Leu5]enkephalin from dynorphin A(1-8) by rat central nervous tissue in vitro.
Dixon DM; Traynor JR
J Neurochem; 1990 Apr; 54(4):1379-85. PubMed ID: 1968961
[TBL] [Abstract][Full Text] [Related]
16. Evidence that the agonist action of dynorphin A(1-8) in the guinea-pig myenteric-plexus may be mediated partly through conversion to [Leu5]enkephalin.
Dixon DM; Traynor JR
Br J Pharmacol; 1990 Nov; 101(3):674-8. PubMed ID: 1981690
[TBL] [Abstract][Full Text] [Related]
17. Protection against dynorphin-(1-8) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon.
Hiranuma T; Kitamura K; Taniguchi T; Kanai M; Arai Y; Iwao K; Oka T
J Pharmacol Exp Ther; 1998 Aug; 286(2):863-9. PubMed ID: 9694943
[TBL] [Abstract][Full Text] [Related]
18. Endopeptidase 3.4.24.11 converts N-1-(R,S)carboxy-3-phenylpropyl-Ala-Ala-Phe-p-carboxyanilide into a potent inhibitor of angiotensin-converting enzyme.
Williams CH; Yamamoto T; Walsh DM; Allsop D
Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):681-4. PubMed ID: 8379924
[TBL] [Abstract][Full Text] [Related]
19. Potent inhibition of endopeptidase 24.16 and endopeptidase 24.15 by the phosphonamide peptide N-(phenylethylphosphonyl)-Gly-L-Pro-L-aminohexanoic acid.
Barelli H; Dive V; Yiotakis A; Vincent JP; Checler F
Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):621-5. PubMed ID: 1332678
[TBL] [Abstract][Full Text] [Related]
20. Response of rat pituitary anterior lobe prodynorphin products to changes in gonadal steroid environment.
Molineaux CJ; Hassen AH; Rosenberger JG; Cox BM
Endocrinology; 1986 Nov; 119(5):2297-305. PubMed ID: 2876888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
